A diversity outbred F1 mouse model identifies host-intrinsic genetic regulators of response to immune checkpoint inhibitors

Immune checkpoint inhibitors (ICI) have improved outcomes for a variety of malignancies; however, many patients fail to benefit. While tumor-intrinsic mechanisms are likely involved in therapy resistance, it is unclear to what extent host genetic background influences response. To investigate this,...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Justin B. Hackett, James E. Glassbrook, Maria C. Muñiz, Madeline Bross, Abigail Fielder, Gregory Dyson, Nasrin Movahhedin, Jennifer McCasland, Claire McCarthy-Leo, Heather M. Gibson
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Taylor & Francis Group 2022-12-01
Sarja:	OncoImmunology
Aiheet:	Immune checkpoint inhibitor genetic linkage analysis immunotherapy resistance melanoma prolactin diversity outbred
Linkit:	https://www.tandfonline.com/doi/10.1080/2162402X.2022.2064958
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!